Weather , , 0°C

Chronic Refractory Cough Market to Witness Growth at a CAGR of 6.57% during the Study Period 2018-2030 | DelveInsight

 Breaking News
  • No posts were found

Chronic Refractory Cough Market to Witness Growth at a CAGR of 6.57% during the Study Period 2018-2030 | DelveInsight

July 07
20:36 2021
Chronic Refractory Cough Market to Witness Growth at a CAGR of 6.57% during the Study Period 2018-2030 | DelveInsight

Chronic Refractory Cough Market

Chronic refractory cough is defined as a cough lasting more than 8 weeks that persists despite guidelines based treatment which may be treated by different medical specialties: Pulmonology, Allergy and Immunology, Digestive Health and Otorhinolaryngology. Patients with chronic cough experience impaired quality of life and interruption of activities of daily living. It can result in depression and can persist for many months or years, despite systematic investigation and treatment of known causes.

 

DelveInsight’s ‘Chronic Refractory Cough Market Insights, Epidemiology and Market Forecast 2030’ report delivers an in-depth understanding of the Chronic Refractory Cough, historical and forecasted epidemiology as well as the Chronic Refractory Cough market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some Facts of the Chronic Refractory Cough Market are:

  • Chronic Refractory Cough market size in the seven major is expected to show a positive growth at a CAGR of 6.57% during the study period 2018–2030.
  • The total prevalent population of Chronic Cough in the 7 major markets was estimated to be 84,854,266 in 2020.
  • The prevalent population of Chronic Refractory Cough in the 7 major markets was estimated to be 17,600,264 in 2020.
  • The total diagnosed prevalent population of Chronic Refractory Cough in the 7 major markets was estimated to be 10,560,159 in 2020. In case of Chronic Refractory Cough patients in the United States, the diagnosed prevalent cases were 4,802,273 in 2020.
  • In the EU5 countries, the prevalent population of Chronic Cough was maximum in France with 8,799,771 cases, followed by the United Kingdom with 8,682,007 cases in 2020.

 

Request for Free Sample Report: https://www.delveinsight.com/report-store/chronic-refractory-cough-market

 

Chronic Refractory Cough is caused due to the recurrent occurrence of chronic cough. However, the signs and symptoms of chronic cough are similar to that of Chronic Refractory Cough. Persistent or chronic cough is one of the first and important symptoms and may signify respiratory involvement. Other pulmonary symptoms and signs include wheezing, stridor, dyspnea, hoarseness or aphonia, and tenderness over the laryngotracheal cartilage. Key symptoms include a dry irritating cough localized around the laryngeal region. Certain factors like smoking, allergies, chronic lung diseases, obesity and others can increase the risk of Chronic Refractory Cough.

 

Some of the Chronic Refractory Cough Companies are:

  • Merck
  • Nerre Therapeutics
  • Bellus Health
  • Shionogi
  • Bayer
  • And Many Others

 

Request for Free Sample Report: https://www.delveinsight.com/report-store/chronic-refractory-cough-market

 

Chronic Refractory Cough Drugs Covered:

  • Gefapixant
  • Orvepitant Maleate
  • BLU-5937
  • S-600918
  • BAY1817080 (Eliapixant)
  • And Many Others

 

Request for Free Sample Report: https://www.delveinsight.com/report-store/chronic-refractory-cough-market

 

Table of Contents:

1

Key Insights

2

Uncomplicated Urinary Tract Infection Market Report Introduction

3

Uncomplicated Urinary Tract Infection Market Overview at a Glance

4

Executive Summary of Uncomplicated Urinary Tract Infection

5

Disease Background and Overview

6

Algorithm for Diagnosis of Uncomplicated Urinary Tract Infection 

7

Patient Journey

8

Prevention

9

Uncomplicated Urinary Tract Infection Epidemiology and Patient Population

10

Treatment Algorithm, Current Treatment, and Medical Practices

11

Uncomplicated Urinary Tract Infection Epidemiology and Patient Population

10

Country Wise-Epidemiology of Uncomplicated Urinary Tract Infection

12

Uncomplicated Urinary Tract Infection Treatment 

13

Unmet Needs

14

Key Endpoints of Uncomplicated Urinary Tract Infection Treatment

15

Uncomplicated Urinary Tract Infection Emerging Therapies

16

Uncomplicated Urinary Tract Infection: 7 Major Market Analysis

17

Uncomplicated Urinary Tract Infection Market Unmet Needs 

18

Uncomplicated Urinary Tract Infection Market Access and Reimbursement

19

Uncomplicated Urinary Tract Infection Market Drivers

20

Uncomplicated Urinary Tract Infection Market Barriers

21

SWOT Analysis

21

KOL Reviews

22

Appendix

23

DelveInsight Capabilities

24

Disclaimer

25

About DelveInsight

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/chronic-refractory-cough-market

Related Articles